RD Saúde

RD Saúde, formerly known as Raia Drogasil and later as RD, is a Brazilian company focused on pharmacy retailing, health products, healthcare services, and digital health-related channels. Its operating history combines two established Brazilian drugstore businesses: Droga Raia, founded in 1905, and Drogasil, founded in 1935. The two companies merged in 2011, creating Raia Drogasil, a national-scale pharmacy retailer whose stores continued to operate primarily under the Raia and Drogasil names. The company is headquartered in São Paulo and has built a nationwide retail network covering all 27 Brazilian states. Its business is supported by a large store base, distribution infrastructure, digital commerce, mobile applications, and a broad customer relationship platform. Reference material describes the company as having more than 3,000 pharmacies and, in another count, approximately 3,614 stores across Brazil. Its pharmacies are supplied through 14 distribution centers. The company is described as the largest drugstore company in Latin America by revenue and market capitalization, although the precise financial figures and market-capitalization data require time-specific financial sources. The Raia and Drogasil banners remain central to the consumer-facing business. Stores sell prescription and over-the-counter medicines, personal-care products, beauty products, infant and household health-related items, and other pharmacy merchandise. The company also operates proprietary websites and mobile applications for the Raia and Drogasil brands. Publicly filed information cited in the reference material indicates that digital channels represented 15.2% of retail gross revenue in 2023. In 2015, the company entered the Ibovespa, Brazil's principal stock-market index. In 2017, it changed its corporate brand from Raia Drogasil to RD, separating the corporate identity from the two principal retail banners. In 2024, the company adopted the RD Saúde identity as part of a broader strategic repositioning. The change reflected an ambition to evolve from a conventional pharmacy retailer into an integrated health provider. The RD Saúde strategy is organized around four stated areas: health promotion, prevention, protection, and primary care. These areas are intended to use the company's physical proximity, customer relationships, digital channels, and pharmacy network to support healthier lifestyles, monitoring and management of chronic conditions, vaccination and immunization, and diagnosis or treatment of acute, low-complexity conditions. The company describes this broader model as serving more than 47.5 million active customers and holding approximately 15.5% market share; those figures should be interpreted in relation to the company's stated reporting period and market definition. RD Saúde competes in Brazil with other pharmacy groups, including Grupo DPSP, Pague Menos, and Farmácias São João. Its competitive position is based on national reach, recognizable pharmacy banners, purchasing and distribution scale, store density, digital access, and the ability to connect retail pharmacy with additional health services. The company remains active and continues to operate primarily in Brazil.

RD Saúde traces its operating heritage to two Brazilian pharmacy businesses. Droga Raia was founded in 1905, while Drogasil was founded in 1935. Both companies developed as pharmacy retailers and were publicly listed in Brazil before their combination. Their long operating histories gave the merged business two established retail identities and a foundation for national expansion. In 2011, Droga Raia and Drogasil merged to form Raia Drogasil. The transaction created a large Brazilian drugstore group while preserving the Raia and Drogasil names for the store network. The combined company expanded through a mixture of organic growth, distribution investment, store openings, and the integration of physical and digital retail. Its headquarters were established in São Paulo, and its pharmacy network eventually reached all 27 Brazilian states. The merged company developed a substantial logistics structure to supply its stores. Reference material identifies 14 distribution centers serving the network. The physical footprint became the main point of contact with consumers, while the company also invested in websites and mobile applications for the Raia and Drogasil banners. These digital channels allowed customers to access pharmacy products and services beyond the individual store and became an increasingly important part of the retail model. A significant capital-markets milestone came in 2015, when the company was included in the Ibovespa, Brazil's main stock-market index. Inclusion reflected the importance and liquidity of the listed company within the Brazilian equity market, although the available reference material does not provide the specific inclusion date or the company's ticker. In 2017, the corporate brand was changed from Raia Drogasil to RD. This change created a distinction between the corporate identity and the two major retail banners. Raia and Drogasil continued to identify the pharmacies seen by consumers, while RD served as the shorter corporate name. The company later broadened its strategic ambitions. In 2024, it adopted the RD Saúde identity, signaling a move beyond the description of the business as simply a drugstore retailer. The new positioning presents the company's stores, digital channels, pharmacists, customer base, and health-related services as components of an integrated health platform. The RD Saúde model is described through four pillars. Health promotion concerns encouraging, educating, and supporting healthier lifestyles. Prevention concerns monitoring and treating chronic conditions. Protection includes measures such as vaccination and immunization. Primary care concerns the diagnosis and treatment of acute, low-complexity conditions. Together, these pillars seek to use the company's extensive retail presence as an accessible point of contact within the Brazilian healthcare system. The company operates in a competitive Brazilian pharmacy market. Named competitors include Grupo DPSP, Pague Menos, and Farmácias São João. RD Saúde's stated advantages include its nationwide network, supply-chain scale, two widely recognized pharmacy banners, digital reach, and a large base of active customers. Reference material describes more than 3,000 pharmacies, with a separate count reporting 3,614 stores, and identifies more than 47.5 million active customers and an approximately 15.5% market share. The same material reports that online channels accounted for 15.2% of retail gross revenue in 2023. These operating figures are dependent on company reporting definitions and periods. RD Saúde remains an active Brazilian company. Its present identity combines the legacy of Droga Raia and Drogasil with a stated ambition to connect pharmacy retail, digital commerce, prevention, health promotion, protection, and primary care.

• 2024

  Corporate identity changes to RD Saúde

  [1]RD S.A.en.wikipedia.org

  The company adopted RD Saúde as it repositioned itself as a broader health provider.

• 2017

  Corporate name changes to RD

  [1]RD S.A.en.wikipedia.org

  The corporate brand changed from Raia Drogasil to RD, while the Raia and Drogasil retail banners continued.

• 2015

  Included in the Ibovespa

  [1]RD S.A.en.wikipedia.org

  The company was included in the Ibovespa, Brazil's principal stock-market index.

• 2011

  Droga Raia and Drogasil merge

  [1]RD S.A.en.wikipedia.org

  The two listed pharmacy companies merged to create Raia Drogasil.

• 1935

  Drogasil founded

  [1]RD S.A.en.wikipedia.org

  Drogasil, the second predecessor company, was founded in Brazil.

• 1905

  Droga Raia founded

  [1]RD S.A.en.wikipedia.org

  Droga Raia, one of the two predecessor pharmacy companies, was founded in Brazil.

A nationwide Brazilian pharmacy and health platform combining large-format retail reach, digital commerce, pharmacy services, and a broader integrated-health strategy.

• Pharmacy retail chain · 1905

  Raia

  Raia is one of RD Saúde's two principal consumer-facing pharmacy banners. Its stores provide prescription and non-prescription medicines, personal-care and beauty products, health-related consumer goods, and access to pharmacy services. The banner derives from Droga Raia, whose operating history dates to 1905, and forms part of the company's nationwide physical retail network.

• Pharmacy retail chain · 1935

  Drogasil

  Drogasil is RD Saúde's second principal pharmacy banner. It sells prescription and over-the-counter medicines, personal-care products, beauty items, and other pharmacy merchandise, and supports the company's broader health-service strategy. The banner derives from Drogasil, founded in 1935, and continues to operate alongside Raia after the 2011 merger.

• Digital pharmacy commerce

  Raia and Drogasil digital channels

  RD Saúde operates proprietary websites and mobile applications associated with the Raia and Drogasil brands. These channels extend access to the company's pharmacy assortment and support its omnichannel retail model. Publicly filed information cited in the reference material states that online channels represented 15.2% of retail gross revenue in 2023.

• Healthcare services · 2024

  RD Saúde integrated health services

  Under the RD Saúde positioning, the company presents its store network and digital ecosystem as a platform for health promotion, prevention, protection, and primary care. The stated scope includes support for healthier lifestyles, chronic-condition monitoring, vaccination and immunization, and diagnosis or treatment of acute, low-complexity conditions.

• 2024

  Repositioning as RD SaúdeStrategy

  Background

  The company aimed to move from a narrow pharmacy-retailing identity toward a broader health-provider model.

  Action taken

  It adopted RD Saúde as its corporate identity and articulated a strategy based on health promotion, prevention, protection, and primary care.

  Aftermath

  The new positioning links the national pharmacy network and digital channels with a wider set of health-related services.

  Source

• 2017

  Corporate rebranding from Raia Drogasil to RDStrategy

  Background

  The company sought a corporate identity distinct from its two principal retail banners.

  Action taken

  It changed the corporate brand to RD while retaining Raia and Drogasil as store brands.

  Aftermath

  The corporate and consumer-facing identities were separated, with Raia and Drogasil continuing to operate as pharmacy banners.

  Source

• 2011

  Merger creating Raia DrogasilM&A

  Background

  Droga Raia and Drogasil were two established Brazilian pharmacy companies with listed histories.

  Action taken

  The companies merged to form Raia Drogasil and combined their pharmacy-retail operations.

  Aftermath

  The merger created a national-scale pharmacy group that continued operating stores under the Raia and Drogasil banners.

  Source

• 2024

  RD Saúde adopts a broader health-platform identity[1]RD S.A.en.wikipedia.org

  Other

  The company adjusted its corporate brand to RD Saúde as it repositioned itself from a pharmacy retailer toward a more integrated health provider.

• 2017

  Raia Drogasil changes corporate brand to RD[1]RD S.A.en.wikipedia.org

  Other

  The company moved from the corporate identity Raia Drogasil to the shorter RD name while retaining Raia and Drogasil as its principal consumer-facing pharmacy banners.

1. 1RD S.A.en.wikipedia.org